Patent ID: 6495532
Filing Date: 2002-12-17
Classification: A61K,B82Y

Abstract:
A composition comprising a therapeutically effective amount of an LPA selected from the group consisting ofOleyl 1-thiophosphoryl-2-O-Methyl-rac-glycerate, 1-(3-propyl oleoate)thiophosphate, 3-O-Oleoyl-2-O-methyl-rac-glycero-1-thiophosphate, 3-O-Oleyl-2-O-methyl-rac-glycero-1-thiophosphate, 3-O-Oleyl-2-O-methyl-rac-glycero-1-phosphate, 3-O-Oleyl-rac-glycero-1-phosphate, 3-O-Oleyloxypropyl-1-phosphate and 1-(3-propyl oleoate)phosphate and a potentiating component in an amount sufficient to potentiate the therapeutic effectiveness of the LPA.